AVOBENZONE 3%, HOMOSALATE 15%, OCTISALATE 5%, OCTOCRYLENE 10%

N/A

Manufactured by Beiersdorf Inc

183 FDA adverse event reports analyzed

Last updated: 2026-04-15

About AVOBENZONE 3%, HOMOSALATE 15%, OCTISALATE 5%, OCTOCRYLENE 10%

AVOBENZONE 3%, HOMOSALATE 15%, OCTISALATE 5%, OCTOCRYLENE 10% is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Beiersdorf Inc. The most commonly reported adverse reactions for AVOBENZONE 3%, HOMOSALATE 15%, OCTISALATE 5%, OCTOCRYLENE 10% include CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR, SUNBURN, PRODUCT EXPIRATION DATE ISSUE, ACCIDENTAL EXPOSURE TO PRODUCT, EYE IRRITATION. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for AVOBENZONE 3%, HOMOSALATE 15%, OCTISALATE 5%, OCTOCRYLENE 10%.

Top Adverse Reactions

CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR21 reports
SUNBURN20 reports
PRODUCT EXPIRATION DATE ISSUE15 reports
ACCIDENTAL EXPOSURE TO PRODUCT7 reports
EYE IRRITATION7 reports
ERYTHEMA6 reports
DRUG INEFFECTIVE4 reports
PAIN4 reports
PRURITUS4 reports
RASH4 reports
RASH MACULAR4 reports
SKIN REACTION4 reports
EYE PAIN3 reports
HYPERSENSITIVITY3 reports
POOR QUALITY DRUG ADMINISTERED3 reports
PRODUCT LOT NUMBER ISSUE3 reports
PRODUCT PHYSICAL CONSISTENCY ISSUE3 reports
SKIN DISCOLOURATION3 reports
APPLICATION SITE DISCOLOURATION2 reports
DIZZINESS2 reports
EXPIRED PRODUCT ADMINISTERED2 reports
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION2 reports
NAUSEA2 reports
OCULAR HYPERAEMIA2 reports
PRODUCT LABEL CONFUSION2 reports
PRODUCT QUALITY ISSUE2 reports
RASH ERYTHEMATOUS2 reports
VOMITING2 reports
APPLICATION SITE ERYTHEMA1 reports
APPLICATION SITE PRURITUS1 reports
ASPHYXIA1 reports
BASAL CELL CARCINOMA1 reports
BLINDNESS1 reports
BLINDNESS TRANSIENT1 reports
BLISTER1 reports
BURNING SENSATION1 reports
CHEMICAL INJURY1 reports
CONDITION AGGRAVATED1 reports
DERMATITIS CONTACT1 reports
DISCOMFORT1 reports
DRUG EFFECT DECREASED1 reports
DRUG HYPERSENSITIVITY1 reports
EYE BURNS1 reports
EYE PRURITUS1 reports
EYE SWELLING1 reports
FACIAL PAIN1 reports
FEELING HOT1 reports
INCORRECT DRUG ADMINISTRATION DURATION1 reports
LIQUID PRODUCT PHYSICAL ISSUE1 reports
MALAISE1 reports
MALIGNANT MELANOMA1 reports
OCULAR DISCOMFORT1 reports
OFF LABEL USE1 reports
PAPULE1 reports
PERIPHERAL SWELLING1 reports
PRODUCT COLOUR ISSUE1 reports
PRODUCT DISPENSING ERROR1 reports
PRODUCT ODOUR ABNORMAL1 reports
PRODUCT PACKAGE ASSOCIATED INJURY1 reports
PRODUCT USE IN UNAPPROVED INDICATION1 reports
PRODUCT USE ISSUE1 reports
RADIATION SKIN INJURY1 reports
RASH GENERALISED1 reports
RASH PUSTULAR1 reports
SCREAMING1 reports
SKIN CANCER1 reports
SKIN EXFOLIATION1 reports
SKIN SWELLING1 reports
SOMNOLENCE1 reports
SWELLING1 reports
UNDERDOSE1 reports
URTICARIA1 reports
WOUND HAEMORRHAGE1 reports

Report Outcomes

Out of 89 classified reports for AVOBENZONE 3%, HOMOSALATE 15%, OCTISALATE 5%, OCTOCRYLENE 10%:

Serious 10.1%Non-Serious 89.9%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female47 (59.5%)
Male32 (40.5%)

Reports by Age

Age 792 reports
Age 31 reports
Age 51 reports
Age 61 reports
Age 191 reports
Age 211 reports
Age 251 reports
Age 341 reports
Age 551 reports
Age 561 reports
Age 591 reports
Age 691 reports
Age 701 reports
Age 861 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with AVOBENZONE 3%, HOMOSALATE 15%, OCTISALATE 5%, OCTOCRYLENE 10%?

This profile reflects 183 FDA FAERS reports that mention AVOBENZONE 3%, HOMOSALATE 15%, OCTISALATE 5%, OCTOCRYLENE 10%. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for AVOBENZONE 3%, HOMOSALATE 15%, OCTISALATE 5%, OCTOCRYLENE 10%?

Frequently reported terms in FAERS include CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR, SUNBURN, PRODUCT EXPIRATION DATE ISSUE, ACCIDENTAL EXPOSURE TO PRODUCT, EYE IRRITATION, ERYTHEMA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures AVOBENZONE 3%, HOMOSALATE 15%, OCTISALATE 5%, OCTOCRYLENE 10%?

Labeling and FAERS entries often list Beiersdorf Inc in connection with AVOBENZONE 3%, HOMOSALATE 15%, OCTISALATE 5%, OCTOCRYLENE 10%. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.